Roivant Sciences Ltd.
ROIV
71 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Aug 18 8:29 PM | MAYUKH SUKHATME | Proposed Sale | 136,942 | $36.73 | $5.0M | — | View → |
| Aug 17, 2026 | Aug 17 8:40 PM | MAYUKH SUKHATME | Proposed Sale | 284,707 | $36.25 | $10.3M | — | View → |
| Aug 14, 2026 | Aug 14 8:20 PM | MAYUKH SUKHATME | Proposed Sale | 243,177 | $36.23 | $8.8M | — | View → |
| Jul 27, 2026 | Jul 30 1:00 AM | Eric VenkerPresident & Immunovant CEO | Sale | 200,000 | $34.95 | $7.0M | 1,613,063(D) | View → |
| Jul 27, 2026 | Jul 27 8:16 PM | Venker Eric | Proposed Sale | 200,000 | $34.95 | $7.0M | — | View → |
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Sale | 10,000 | $34.90 | $349.0K | 42,963(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Sale | 17,750 | $34.38 | $610.3K | 16,474(D) | View → |
| Jun 30, 2026 | Jul 1 12:38 AM | Keith S ManchesterDirector | Sale | 212,380 | $35.44 | $7.5M | 1,748,403(I) | View → |
| Jun 29, 2026 | Jul 1 12:38 AM | Keith S ManchesterDirector | Sale | 800,000 | $34.55 | $27.6M | 13,701,546(I) | View → |
| Jun 26, 2026 | Jul 1 12:38 AM | Keith S ManchesterDirector | Sale | 625,783 | $34.00 | $21.3M | 14,501,546(I) | View → |
| Jun 30, 2026 | Jul 1 12:30 AM | Daniel Allen GoldDirector | Sale | 12,380 | $35.28 | $436.8K | 13,689,166(I) | View → |
| Jun 29, 2026 | Jul 1 12:30 AM | Daniel Allen GoldDirector | Sale | 800,000 | $34.55 | $27.6M | 13,701,546(I) | View → |
| Jun 26, 2026 | Jul 1 12:30 AM | Daniel Allen GoldDirector | Sale | 625,783 | $34.00 | $21.3M | 14,501,546(I) | View → |
| Jun 30, 2026 | Jun 30 11:59 PM | QVT Financial LPOther | Sale | 12,380 | $35.28 | $436.8K | 13,689,166(I) | View → |
| Jun 29, 2026 | Jun 30 11:59 PM | QVT Financial LPOther | Sale | 800,000 | $34.55 | $27.6M | 13,701,546(I) | View → |
| Jun 26, 2026 | Jun 30 11:59 PM | QVT Financial LPOther | Sale | 625,783 | $34.00 | $21.3M | 14,501,546(I) | View → |
| Jun 30, 2026 | Jun 30 8:36 PM | MEGHAN FITZGERALD | Proposed Sale | 10,000 | $34.73 | $347.3K | — | View → |
| Jun 30, 2026 | Jun 30 8:25 PM | KEITH S MANCHESTER | Proposed Sale | 200,000 | $35.45 | $7.1M | — | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Sale | 500,000 | $34.08 | $17.0M | 18,677,617(D) | View → |
| Jun 25, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Sale | 500,000 | $34.13 | $17.1M | 18,677,617(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 5 10:05 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 151,416(D) | View → |
| Sep 30, 2026 | Oct 2 9:37 PM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,644,834(D) | View → |
| Sep 16, 2026 | Sep 19 1:00 AM | Keith S ManchesterDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:12 PM | Daniel Allen GoldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:06 PM | Ilan OrenDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 11:01 PM | James C MomtazeeDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:57 PM | Meghan FitzgeraldDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 16, 2026 | Sep 18 10:56 PM | Melissa B, EpperlyDirector | Grant/Award | 10,531 | $39.57 | 10,531(D) | View → |
| Sep 8, 2026 | Sep 11 1:00 AM | Meghan FitzgeraldDirector | Option Exercise | 20,000 | $8.80 | 18,578(D) | View → |
| Aug 28, 2026 | Sep 2 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 3,844,834(D) | View → |
| Aug 21, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 144,756 | $3.85 | 13,224,363(D) | View → |
| Aug 20, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 17,519 | $3.85 | 13,369,119(D) | View → |
| Aug 19, 2026 | Aug 22 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 172,899 | $3.85 | 13,386,638(D) | View → |
| Aug 18, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 136,942 | $3.85 | 13,559,537(D) | View → |
| Aug 17, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 284,707 | $3.85 | 13,696,479(D) | View → |
| Aug 14, 2026 | Aug 19 1:00 AM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 243,177 | $3.85 | 13,981,186(D) | View → |
| Jul 27, 2026 | Jul 30 1:00 AM | Eric VenkerPresident & Immunovant CEO | Option Exercise | 200,000 | $3.85 | 4,044,834(D) | View → |
| Jun 30, 2026 | Jul 2 11:03 PM | Meghan FitzgeraldDirector | Option Exercise | 10,000 | $8.80 | 38,578(D) | View → |
| Jun 29, 2026 | Jul 1 10:34 PM | Melissa B, EpperlyDirector | Option Exercise | 17,750 | $4.46 | 169,166(D) | View → |
| Jun 26, 2026 | Jun 29 10:23 PM | Mayukh SukhatmeDirector, President & CIO | Option Exercise | 500,000 | $3.85 | 14,224,363(D) | View → |
Page 1 of 2
Next →